In addition, increased expression of NCOA3, with implications for AR activation, and variation in the length of the polyQ repeat in the NCOA3 gene have been associated with bone cancer, epithelial ovarian cancer, colorectal cancer, and breast cancer in humans [40,41,42,43]. This evidence concerns the gene AR and breast cancer.